United States · FDA National Drug Code directory
TIZANIDINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-8747_6f6e730a-5ef2-4a87-9b1d-8cc2b6aa9989
- Product NDC
- 68788-8747
- Form
- CAPSULE
- Composition / generic term
- tizanidine hydrochloride
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240926
- Source listing expiry
- 20261231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE, PLASTIC (68788-8747-1) · 68788-8747-1
- 20 CAPSULE in 1 BOTTLE, PLASTIC (68788-8747-2) · 68788-8747-2
- 30 CAPSULE in 1 BOTTLE, PLASTIC (68788-8747-3) · 68788-8747-3
- 60 CAPSULE in 1 BOTTLE, PLASTIC (68788-8747-6) · 68788-8747-6
- 120 CAPSULE in 1 BOTTLE, PLASTIC (68788-8747-8) · 68788-8747-8
- 90 CAPSULE in 1 BOTTLE, PLASTIC (68788-8747-9) · 68788-8747-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →